Streetbeat News

Products Services

CRL

Charles River Laboratories has partnered with the FOXG1 Research Foundation to advance AAV9 gene therapy clinical trials. This collaboration leverages Charles River's expertise in plasmid and viral vector CDMO to drive drug development for FOXG1 Syndrome and related neurological disorders.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:13 pm

JBLU

JetBlue Airways Corporation (NASDAQ:JBLU) reported better-than-expected Q2 2024 earnings, with an adjusted EPS of $0.08 and operating revenue of $2.428 billion. The company unveiled its JetForward strategy, targeting $800M-$900M incremental EBIT by 2027. Despite a decline in operating margin and revenue, JBLU shares rose 4.22% premarket.

Portfolio Pulse from Akanksha Bakshi

July 30, 2024 | 12:13 pm

OLO

GRUBBRR has partnered with Olo to enhance restaurant operations by integrating self-ordering kiosks and digital menu boards with Olo's ordering and payment processing capabilities.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:13 pm

SCOR

Comscore has announced a new comprehensive measurement system for YouTube audiences across all digital devices in the US.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:12 pm

ATNF

180 Life Sciences Corp. (NASDAQ:ATNF) announced positive topline results from a clinical pharmacology study comparing two solid formulations of CBD with the FDA-approved drug Epidiolex. The study found that one of the solid forms was absorbed faster and exhibited higher maximal levels compared to Epidiolex.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:11 pm

CVS

PHAT

CVS Caremark has added VOQUEZNA tablets, developed by Phathom Pharmaceuticals, to its national formularies, making it accessible to over 116 million commercially covered lives. This is the first FDA-approved PCAB for GERD treatment in over 30 years.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:11 pm

PCSA

Processa Pharmaceuticals shares are trading higher after the company announced FDA clearance of its IND application for a Phase 2 clinical trial of NGC-Cap in breast cancer.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:10 pm

WKSP

Worksport Ltd. (NASDAQ: WKSP) has announced a partnership with Firework to launch a new live sales platform. The first live session is scheduled for August 6th at 12 PM ET, aiming to enhance customer engagement.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:10 pm

CTGO

Contango ORE, Inc. (NYSE:CTGO) has commenced a surface drilling campaign at the newly acquired Johnson Tract property. The campaign targets 3,000 meters across 20 drill holes and includes hydrological testing and advanced metallurgical analysis. The program is expected to last three months.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:09 pm

BTOC

MAMO

Armlogi Holding Corp. (NASDAQ:BTOC) has leased a new warehouse facility in City of Industry, CA, to support its expanding trucking operations and strategic partnership with Massimo Group (NASDAQ:MAMO).

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:08 pm